Create Alert
Watchlist
₹359.50
-2.65 (0.73%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
360.65
Prev. Close
362.15
Volume
8,36,722
Total traded value
30.08 Cr
Upper Circuit
398.35
Lower Circuit
325.95

Fundamentals

Market Cap₹48,391Cr
ROE4.68%
P/E Ratio(TTM)125.68
EPS(TTM)2.88
P/B Ratio1.85
Dividend Yield0.12%
Industry P/E35.77
Book Value195.54
Debt to Equity0.85
Face Value5
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Biocon

Biocon Group is a global biopharmaceutical company dedicated to delivering high-quality, affordable medicines like generics and biosimilars to patients around the world. The company's core belief is that the right to health begins with access to affordable medicines, which is fundamental to creating a lasting global impact. Through its generics and biosimilars segments, the company has benefited over 21.2 million patients.;
Parent OrganisationBiocon Limited
Managing DirectorMr. Siddharth Mittal
NSE SymbolBIOCON

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
54.45%
Retail And Others
16.68%
Mutual Funds
15.24%
Other Domestic Institutions
7.59%
Foreign Institutions
6.04%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Anthem Biosciences
NA
(0.00%)
103.25
Onesource Specialty Pharma
NA
(0.00%)
302.92
Advanced Enzyme Technologies
NA
(0.00%)
27.63
Panacea Biotec
NA
(0.00%)
218.40